Admera Health
UEI: WQN1JED965X5
• CAGE: 7BR03
Overview
Awardee Type
Parent
Company Description
Admera Health provides genomic and bioinformatic services for researchers
working on projects ranging from exploratory to clinical. Operating in a
CLIA/CLEP-certified and CAP-accredited environment, all projects are
handled with exceptional care.
Name
Admera Health
Website
Headquarters
South Plainfield, NJ
United States
United States
Most Recent Award
May 12, 2026
Calculating
Federal contract recipient
ADMERA HEALTH LLC
(UEI WQN1JED965X5, CAGE 7BR03)
is headquartered in South Plainfield NJ.
Its primary registered NAICS is 541380 Testing Laboratories and Services.
The partnership
was founded in July 2014 and
federally registered in
February 2015.
Federal Award Analysis
Admera Health federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ADMERA HEALTH LLC
UEI
WQN1JED965X5
CAGE Code
7BR03
Primary NAICS
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Minority Owned Business
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 1, 2014
Initial Registration
Feb. 23, 2015
Last Registration
March 3, 2026
Registration Activation
March 3, 2026
Registration Expiration
Feb. 27, 2027
Fiscal Year End
May 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Admera Health
GSA Schedules and Price Lists
- Admera Health
- PoP: 10/14/20 - 10/14/21 (Ended)
- Type: Medical Laboratory Testing and Analysis Services (FSS 621 II)